Alexion Pharmaceuticals Institutional Account Manager, Coagulation, Houston W, TX in Houston, Texas
The Institutional Account Manager (IAM) position is within our Complement Coagulation Franchise. The IAM will be assigned a sales territory focused on Key Institutions growth and expansion of the Coagulation portfolio and other products, following FDA approval, for providers addressing life-threatening bleeds, primarily, though not exclusively, within Academic Medical Centers and IDN stroke/trauma centers and large Community Hospitals. The Institutional Account Manager is responsible for sales achievement and relationship development across the entire patient journey within aligned institutions and surrounding hospital service areas. Products are promoted as appropriate and in-serviced throughout call points throughout the hospital.
Job Duties & Responsibilities
Consistently achieves or exceeds sales objectives in assigned territory and be expected to execute tailored hospital selling in a competitive environment in a manner that drives results
Creates and maintains strategically targeted account-specific business plans that reflect an in-depth understanding of local market forces impacting product sales
Develop and maintain strong in-depth clinical, technical, and scientific knowledge of Andexxa and relevant disease states
Collaborate closely with stakeholders, including Regional Account Manager(s), Complement IAM(s), TLL(s), SAL(s), MSL(s) and Market Access, Diagnostics, and enterprise partners
Requires the ability to handle customer questions and objections in a way that is consistent with product indications and sales training methodology, including ability to compliantly triage inquiries to appropriate partner
Leads the implementation for our patient-centric partnership model which will include physicians, their staff, patients, clinics, and hospitals
Tracks activities and submits reports on sales activities accurately & on-time
Proactively interacts with Alexion management to refine product and market initiatives
Perform work in alignment with and adheres to all Alexion’s Code of Ethics and Business Conduct and Alexion policies and procedures
6 years Biotechnology/Pharmaceutical sales experience, including 3 years biotechnology/Pharmaceutical sales experience calling on Institutions and Hospital Systems
Effectively manages the complexity of systems approach and has developed multidisciplinary teams in Institutions, such as Trauma and Stroke Centers of Excellence
Proven, documented track record for delivering consistent, 'Top-tier' sales results in Institutions and hospital systems
Ability to work effectively independently and in an interdependent, team-oriented environment on a consistent basis
Demonstrated ability to successfully seek out and qualify leads and profile new accounts and stakeholders
Ability to gain consistent access & develop strong, professional relationships for scientific exchange and promotion with healthcare providers in community and academic centers
Effective administrator who efficiently manages time, CRM tool, resources, and workload
Effective verbal and written communication skills and organizational abilities
Ability to travel within territory on a regular basis which will include frequent overnight and weekend travel
Valid driver's license and clean driving record
Advanced or master’s degree
Sales experience in the thrombosis or cardiovascular space
Some opportunities happen only once in a lifetime - like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, metabolic disorders and cardiology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.
As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.